Paydirt
DP
Insider

Dinesh V Ph D Patel

President and CEO

Dinesh V Ph D Patel (President and CEO) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $18.2M of PTGX (125,000 sh across 3 lots, as filed), executed Sep 8.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$60.6M
shares × price, as filed
Last traded
Sep 10
Filed Sep 10

Median ADV $107.4M across their filed names

Open performance
Volume by month
$18.2M$9.1M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $4.7MFeb 2025 · sells $205KJul 2025 · sells $3.5MJan 2026 · sells $6.9MMar 2026 · sells $5.5MMay 2026 · sells $15.0MAug 2026 · sells $14.9MSep 2026 · sells $18.2M
Buys $0 Sells $68.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names
PTGX Protagonist Therapeutics, Inc. PTGX · 0 buys · 11 sells 11 filings
Recent filings
PTGXSALE Protagonist Therapeutics, Inc. View filing → $2.9M
52,444 sh across 3 lots
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET
PTGXSALE Protagonist Therapeutics, Inc. View filing → $205K
5,359 sh × $38.18
Exec Feb 19 2025
Filed Feb 20 2025 · 5:30 PM ET
PTGXSALE Protagonist Therapeutics, Inc. View filing → $4.7M
100,000 sh across 2 lots
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET